Royce & Associates LP Invests $220,000 in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Royce & Associates LP purchased a new position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAYFree Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 11,595 shares of the medical instruments supplier’s stock, valued at approximately $220,000.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the company. First Eagle Investment Management LLC boosted its position in shares of DENTSPLY SIRONA by 2.5% during the fourth quarter. First Eagle Investment Management LLC now owns 14,500,409 shares of the medical instruments supplier’s stock worth $275,218,000 after purchasing an additional 348,532 shares in the last quarter. Cooke & Bieler LP boosted its position in shares of DENTSPLY SIRONA by 24.3% during the fourth quarter. Cooke & Bieler LP now owns 9,172,876 shares of the medical instruments supplier’s stock worth $174,101,000 after purchasing an additional 1,794,391 shares in the last quarter. FMR LLC boosted its position in shares of DENTSPLY SIRONA by 5.1% during the third quarter. FMR LLC now owns 9,056,774 shares of the medical instruments supplier’s stock worth $245,076,000 after purchasing an additional 436,031 shares in the last quarter. Pacer Advisors Inc. lifted its position in DENTSPLY SIRONA by 15,105.1% in the 4th quarter. Pacer Advisors Inc. now owns 4,503,591 shares of the medical instruments supplier’s stock valued at $85,478,000 after acquiring an additional 4,473,972 shares in the last quarter. Finally, Bank of New York Mellon Corp lifted its position in DENTSPLY SIRONA by 27.9% in the 4th quarter. Bank of New York Mellon Corp now owns 2,403,110 shares of the medical instruments supplier’s stock valued at $45,611,000 after acquiring an additional 523,692 shares in the last quarter. 95.70% of the stock is owned by institutional investors.

Insider Activity at DENTSPLY SIRONA

In related news, Director Gregory T. Lucier purchased 15,142 shares of the firm’s stock in a transaction that occurred on Monday, March 3rd. The shares were acquired at an average price of $16.51 per share, for a total transaction of $249,994.42. Following the purchase, the director now owns 81,971 shares in the company, valued at approximately $1,353,341.21. This represents a 22.66 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 0.52% of the stock is owned by company insiders.

Analysts Set New Price Targets

Several equities research analysts recently commented on XRAY shares. Barrington Research cut their price objective on shares of DENTSPLY SIRONA from $24.00 to $20.00 and set an “outperform” rating on the stock in a research report on Friday, February 28th. Needham & Company LLC reaffirmed a “hold” rating on shares of DENTSPLY SIRONA in a research report on Thursday, March 13th. Morgan Stanley cut their price objective on shares of DENTSPLY SIRONA from $30.00 to $23.00 and set an “overweight” rating on the stock in a research report on Tuesday, December 17th. Robert W. Baird cut their price objective on shares of DENTSPLY SIRONA from $22.00 to $20.00 and set a “neutral” rating on the stock in a research report on Friday, February 28th. Finally, Wells Fargo & Company cut their price objective on shares of DENTSPLY SIRONA from $20.00 to $19.00 and set an “equal weight” rating on the stock in a research report on Friday, February 28th. Twelve equities research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $23.33.

Get Our Latest Stock Report on XRAY

DENTSPLY SIRONA Stock Down 0.3 %

DENTSPLY SIRONA stock opened at $15.56 on Friday. The firm has a market capitalization of $3.10 billion, a PE ratio of -7.52, a P/E/G ratio of 1.80 and a beta of 0.98. The company’s 50-day moving average is $17.92 and its 200-day moving average is $20.53. DENTSPLY SIRONA Inc. has a fifty-two week low of $14.78 and a fifty-two week high of $33.52. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84.

DENTSPLY SIRONA Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Investors of record on Friday, March 28th will be paid a $0.16 dividend. The ex-dividend date is Friday, March 28th. This represents a $0.64 dividend on an annualized basis and a yield of 4.11%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is currently -14.07%.

DENTSPLY SIRONA Profile

(Free Report)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

Featured Articles

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAYFree Report).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.